Rmb Capital Management, LLC Amneal Pharmaceuticals, Inc. Transaction History

Rmb Capital Management, LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2019 Nov 12, 2019	SELL	$2.29 - $7.1 $90,741 - $281,337	-39,625 Closed	0 $0
Q2 2019 Aug 13, 2019	SELL	$6.44 - $14.29 $25,450 - $56,474	-3,952 Reduced 9.07%	39,625 $284,000
Q1 2019 May 15, 2019	SELL	$11.87 - $14.84 $215,820 - $269,820	-18,182 Reduced 29.44%	43,577 $617,000
Q4 2018 Feb 13, 2019	BUY	$13.09 - $21.49 $183,102 - $300,602	13,988 Added 29.28%	61,759 $836,000
Q2 2018 Aug 13, 2018	BUY	$13.95 - $20.2 $666,405 - $964,974	47,771 New	47,771 $0

185

141M

57K

49K

Ticker AMRX
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 151,408,992
Market Cap $1.28B
Description
Amneal Pharmaceuticals, Inc., together with its subsidiaries, develops, licenses, manufactures, markets, and distributes generic and specialty pharmaceutical products for various dosage forms and therapeutic areas. The company operates through three segments: Generics, Specialty, and AvKARE. The Generics segment develops, manufactures, and comme...

Get notified when there are updates to the investment portfolio of Rmb Capital Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Rmb Capital Management, LLC with notifications on news.